Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec 18;9(1):19377.
doi: 10.1038/s41598-019-55848-7.

Pharmacological polysulfide suppresses glucose-stimulated insulin secretion in an ATP-sensitive potassium channel-dependent manner

Affiliations

Pharmacological polysulfide suppresses glucose-stimulated insulin secretion in an ATP-sensitive potassium channel-dependent manner

Tomohiro Shoji et al. Sci Rep. .

Abstract

Hydrogen sulfide (H2S) is an endogenous gaseous transmitter synthesized in various cell types. It is well established that H2S functions in many physiological processes, including the relaxation of vascular smooth muscle, mediation of neurotransmission, regulation of inflammation, and modulation of insulin signaling. In recent years, it has been revealed that polysulfides, substances with a varying number of sulfur atoms (H2Sn), are generated endogenously from H2S in the presence of oxygen. A series of studies describes that sulfane sulfur has the unique ability to bind reversibly to other sulfur atoms to form hydropersulfides and polysulfides, and that polysulfides activate ion channels and promote calcium influx. Furthermore, polysulfides regulate tumor suppressor activity, promote the activation of transcription factors targeting antioxidant genes and regulate blood pressure by vascular smooth muscle relaxation. Insulin secretion from pancreatic β cells plays a critical role in response to increased blood glucose concentration. H2S has emerged as an important regulator of glycemic control and exhibits characteristic regulation of glucose homeostasis. However, the effects of polysulfides on glucose-stimulated insulin secretion (GSIS) are largely unknown. In this study, we demonstrated that pharmacological polysulfide salts including Na2S2, Na2S3, and Na2S4 considerably inhibit GSIS in mouse and rat pancreatic β-cell-derived MIN6 and INS-1 cell lines, and that the effect is dependent on the activation of ATP-sensitive potassium channels. In addition, we demonstrated that a mixture of Na2S and diethylamine NONOate inhibits GSIS in a similar way to the pharmacological administration of polysulfide salts.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Dose- and time-dependent effects of polysulfide salt, sodium tetrasulfide (Na2S4) on glucose-stimulated insulin secretion in MIN6 cells. (a,b) Mouse MIN6 cells were exposed to Na2S4 (0, 1.5, 3.1, 6.2, 12.5, 25 and 50 µM) for 4 h under 2 mM glucose conditions, and insulin secretion was determined in the presence of 2 mM (a) or 20 mM glucose (b) (n = 5). (c) MIN6 cells were treated with 20 mM glucose (glu), sucrose (suc) or maltose (mal) for 1 h (n = 8). (d) MIN6 cells were exposed to Na2S4 (0, 1.5, 3.1, 6.2, 25, and 50 µM) for 1 h or 4 h and then insulin secretion was determined under 20 mM glucose conditions. (n = 5) (e) MIN6 cells were exposed to Na2S4 for 4 h and then to 20 mM glucose or incubated for 6 h without Na2S4 and then insulin secretion was determined in 20 mM glucose conditions (n = 3). Data are presented as mean ± SD. Differences between treatments were evaluated by one-way ANOVA followed by Dunnett’s test for multiple comparisons; #P < 0.05, as compared with the control: (Na2S4 0 µM: a and b). *P < 0.05 for comparison of the indicated groups (c, d, and e).
Figure 2
Figure 2
Effects of hydrogen sulfide donor and polysulfide salts on glucose-stimulated insulin secretion in MIN6 cells and its dependency of S-S bonds. (a) Mouse MIN6 cells were exposed to Na2S, Na2S2, or Na2S3 (0, 6.2,12.5, 25 and 50 µM) for 1 h in the presence of 2 mM glucose and then insulin secretion was determined in 20 mM glucose. (n = 3) (b) MIN6 cells were exposed to Na2S or DEA/NO in 2 mM or 20 mM glucose. (n = 3) (c) MIN6 cells were exposed to Na2S or Na2S4 in 20 mM glucose. (n = 3) (d,e) MIN6 cells were exposed to 50 µM Na2S or 50 µM Na2S4 with 250 µM tris (2-carboxyethyl) phosphine hydrochloride (TCEP) (d) or Na2S or Na2S4 treated by immobilized-TCEP (iTCEP). (n = 3) (e) for 1 hour and then insulin secretion was determined under 20 mM glucose conditions. (n = 3) Data are presented as mean ± SD (n = 3). Differences between treatments were evaluated by one-way ANOVA followed by Dunnett’s test for multiple comparisons; #P < 0.05, as compared with the control (0 µM Na2S4: 20 mM or 10 mM glucose)
Figure 3
Figure 3
Dose- and time-dependent effects of polysulfide salts on glucose-stimulated insulin secretion in INS-1 cells and mouse pancreatic β-cells/islets. (a,b) Rat insulinoma INS-1 cells were exposed to Na2S4 (0, 0.05, 0.5, 5, or 50 µM) for 1 h in the presence of 2 mM glucose and then insulin secretion was determined under 2 mM (a) or 10 mM (b) glucose conditions. (n = 3) (c) INS-1 cells were exposed to 50 µM Na2S, Na2S2, Na2S3, or Na2S4 for 1 h in 2 mM glucose and then insulin secretion was determined under 20 mM glucose conditions (n = 3). (d) Mouse pancreatic β-cells/islets were exposed to 50 µM Na2S4 for 1 h in 2 mM or 20 mM glucose (n = 3). In the case of β-cells/islets insulin concentrations were compensated with total protein weight. Data are presented as mean ± SD (n = 3). Differences between treatments were evaluated by one-way ANOVA followed by Dunnett’s test for multiple comparisons; #P < 0.05, as compared with the control (Na2S3 or Na2S4 0 µM).
Figure 4
Figure 4
Impact of Na2S4 on death of mouse MIN6 cells. (a,b) MIN6 cells were exposed to Na2S4 at doses from 0 µM to 100 µM and to lidocaine as positive control at 10 mM and cultured for periods ranging from 0 h to 4 h prior to cell viability evaluation. Cell death was also assayed by flow cytometry (a) and trypan blue exclusion method (b). Differences between treatments were evaluated by one-way ANOVA followed by Dunnett’s test for multiple comparisons; #P < 0.05, as compared to the control cell population (Na2S4 ;0 µM, lidocaine; 0 mM treatment).
Figure 5
Figure 5
Effects of Na2S4 on cellular energy metabolism. (a) Mouse MIN6 cells were cultured from 1 h to 4 h with 25 µM Na2S4 prior to determination of the cellular ATP level (n = 3) under 2 mM or 20 mM glucose conditions. (b,c) Mouse MIN6 cells were exposed to Na2S4 (0, 1.5, 3.1, 6.2, 12.5, 25 and 50 µM) for a period of 4 h, followed by oxygen consumption rate (OCR) assay (b) and extracellular acidification rate (ECAR) assay (c) (n = 9). Differences between treatments were evaluated by one-way ANOVA followed by Dunnett’s test for multiple comparisons; #P < 0.05, as compared to the control cell population (Na2S4 0 µM, glucose 20 mM). *P < 0.05 for comparison of the indicated groups.
Figure 6
Figure 6
Effects of polysulfide salts on insulin secretion induced by glibenclamide. (a,b) Mouse MIN6 cells were exposed to Na2S4 (a) or Na2S3 (b) (0, 6.2, 12.5, 25, or 50 µM) for 4 h without or with glibenclamide (10 µM) under 2 mM or 20 mM glucose conditions (n = 3). (c) MIN6 cells were exposed to 60 mM K+ with Na2S4 (n = 3). Insulin secretion was determined as described in Materials and Methods. Data are presented as the mean ± SD (n = 4). Differences between treatments were evaluated by one-way ANOVA followed by Dunnett’s test for multiple comparisons; #P < 0.05, as compared with the control (glucose = 2 mM, without glibenclamide or without diazoxide treatment or without high K+ treatment).
Figure 7
Figure 7
Effects of Na2S4 on the membrane potential of mouse MIN6 cells. (a) Mouse MIN6 cells were exposed to 50 µM Na2S with 20 mM glucose and harvested. Then the mRNA levels of Kir6.2, and SUR1 were assayed by qRT-PCR. Data are presented as mean ± SD (n = 3). #P < 0.05, as compared with the control (Na2S4 0 µM). (b) Na2S4 (50 μM) induced hyperpolarization of membrane potential with gramicidin-perforated patch. Glibenclamide (Glb; 100 μM) induced depolarization. These traces are representative of six glucose-responsive cells. (c) Representative current–voltage relationships for the whole-cell currents with gramicidin-perforated patch. The current was elicited by a voltage ramp from −123 to −43 mV with a rate of 0.2 V/s. Na2S4 (50 μM) increased the current in the KRBH buffer contained 10 mM glucose (C; control). Thereafter, the current induced by Na2S4 decreased by glibenclamide (Glb, 10 μM). (d) Summary of the effects of Na2S4 and glibenclamide on the conductance (n = 9). *P < 0.05 for comparison of the indicated groups.
Figure 8
Figure 8
Effect of Na2S4 on voltage-dependent outward potassium currents in mouse MIN6 cells. (a) Current–voltage relationships of whole-cell currents with varying concentrations of Na2S4 (in 0, 5, 25, 50, or 500 μM). Na2S4 increased inwardly rectifying potassium currents in a dose-dependent manner (n = 5). (b) Semi-logarithmic plot of the conductance between −108 and −68 mV by concentration of Na2S4 with the standard K+ pipette solution included ATP at 0.01 mM (closed circles) and 1 mM (open circles).

Similar articles

Cited by

References

    1. Kimura H. Hydrogen Sulfide and Polysulfide Signaling. Antioxid Redox Signal. 2017;27:619–621. doi: 10.1089/ars.2017.7076. - DOI - PubMed
    1. Yang W, Yang G, Jia X, Wu L, Wang R. Activation of KATP channels by H2S in rat insulin-secreting cells and the underlying mechanisms. J Physiol. 2005;569:519–531. doi: 10.1113/jphysiol.2005.097642. - DOI - PMC - PubMed
    1. Untereiner A, Wu L. Hydrogen Sulfide and Glucose Homeostasis: A Tale of Sweet and the Stink. Antioxid Redox Signal. 2018;28:1463–1482. doi: 10.1089/ars.2017.7046. - DOI - PubMed
    1. Paul BD, Snyder SH. H(2)S signalling through protein sulfhydration and beyond. Nat Rev Mol Cell Biol. 2012;13:499–507. doi: 10.1038/nrm3391. - DOI - PubMed
    1. Lowicka E, Beltowski J. Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists. Pharmacol Rep. 2007;59:4–24. - PubMed

Publication types

MeSH terms